Healthcare

Healthcare

Inmedix
View On Demand

The diagnostic market for stress-related diseases is $60B. Inmedix has developed a way to measure stress with two recurrent revenue streams and 90% SaaS margins.

Healthcare

Immunicom
View On Demand

Immunicom has developed a hybrid cancer therapy which combines the best of a medical device with targeted drug therapy

Healthcare

Bryologyx
View On Demand

Dr. John Abeles and Bryologyx CEO, Thomas Loarie, share their best practices in healthcare investing.

Healthcare

Preverna
View On Demand

Learn more about Preverna’s revolutionary approach to cancer drug development and how they’re working with others to improve cancer care.

Healthcare

Invectys
View On Demand

Invectys President and CEO, Praveen Tyle, discuses the company’s three platforms and the technology that has the potential to cure metastatic cancers

Healthcare

Medical Bridges
View On Demand

Walter Ulrich, President & CEO of Medical Bridges shares the challenges, issues, and many successes of distributing medical equipment Ukraine.

Healthcare

Inmedix
View On Demand

Inmedix CEO, Andrew J. Holman, MD discusses the company’s upcoming milestones and how their approach to stress testing will transform rheumatology and several other medical specialties.

Healthcare

Assembly Bio
View On Demand

Assembly Bio President and CEO, Dr. John McHutchison discusses the company’s multi-platform approach to curing HBV and the major inflection points ahead this year and next.

Healthcare

BryoLogyx
View On Demand

Bryologyx Founder and CEO, Thomas Loarie discusses the importance of bryostatin, a platform of tumor and antigen stimulating drugs that improve the efficacy of cancer immunotherapies